Anal. Chem., 2021, 93, 1254-1259.
L. Labied, P. Rocchi, T. Doussineau, et al.
Results for "Scaled Agile SAFe-APM シュミレーション問題集: SAFe Agile Product Manager (APM 5.1) - GoShiken 365日無料アップデート 🏴 ウェブサイト“ www.goshiken.com ”を開き、[ SAFe-APM ]を検索して無料でダウンロードしてくださいSAFe-APM試験解説"
2021 – Archives Scientific Publications: AGuIX® Characterization
Unique features of brain metastases – targeted AGuIX nanoparticles vs their constituents: a focus on glutamate-.GABA-ergic neurotransmission in cortex nerve terminals
Food Chem Toxicol., 2021, 149, 112004.
T. Borisova, N. Pozdnyakova, N. Krisanova et al.
Taylor dispersion analysis coupled to inductively coupled plasma mass spectrometry for ultrasmall nanoparticle size measurement : from drug product to biological media studies
Anal. Chem., 2021, 93, 1254-1259
L. Labied, P. Rocchi, T. Doussineau et al.
NH TherAguix announces the release of a new clinical batch for it’s drug AGuIX manufactured by CARBOGEN AMCIS
MEYLAN, France, BUBENDORF, Switzerland (November 3rd, 2021) – NH TherAguix, a clinical stage company developing innovative nanomedicine for the treatment of cancer, and CARBOGEN AMCIS, a pharmaceutical process development and Active Pharmaceutical Ingredient (API) and drug products manufacturing company, announced today the release of a new batch of AGuIX Drug Product for clinical trials.